Chapter 2 ~ Cardiovascular system

Similar documents
Chapter / Section / Drug

5mg/5mL Liquid 25mg Tablets 50mg Tablets 100mg Tablets 50mg/5mL Suspension Special standardise strength 25mg Tablets

Chapter 2 - Cardiovascular System. Primary Care Prescribing Formulary - Preferred Drug Choices

Report generated from BNF provided by FormularyComplete ( Accessed TA Number. Title Formulary Status Section

Beta-blockers. Atenolol. Propranolol. Bisoprolol. Metoprolol. Labetalol. Carvedilol.

ACEBUTOLOL HCL 100MG TABLET GENERIC BETA BLOCKERS ALISKIREN 150MG TABLET RASILAZ RENIN INHIBITOR

ASEBP and ARTA TARP Drugs and Reference Price by Categories

Cardiac Medications At A Glance

Management of Hypertension

Back. Thiazide diuretics Drug Indication Formulation Notes on prescribing Bendroflumethiazide Hypertension, oedema Tablets

2. Cardiovascular System

Antihypertensive Agents

REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.

2. Cardiovascular System

2.1.2 CARDIAC GLYCOSIDES

CARDIAC REHABILITATION PROGRAMME:- MEDICATION

HypertensionTreatment Guidelines. Michaelene Urban APRN, MSN, ACNS-BC, ANP-BC

12.5mg, 25mg, 50mg. 25mg, 50mg. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg. -- $2.81 Acetazolamide (IR, 125mg, 250mg, 500mg (ER)

Select Preventive Prescription Drugs Jan. 1, 2018

Antihypertensive Agents Part-2. Assistant Prof. Dr. Najlaa Saadi PhD Pharmacology Faculty of Pharmacy University of Philadelphia

Cardiovascular drugs

Hypertension (JNC-8)

perioperative management of cardiovascular drugs

Medications and your Heart. RBCH Foundation Trust

Introductory Clinical Pharmacology Chapter 41 Antihypertensive Drugs

Cardiovascular Risk Reduction in Diabetic Mellitus. Presenter: Dr. Martin N. Wanyoike MB.CHB., M. Med.(internal med) Physician / Cardiologist

The ADDITION Study: A study about screening for diabetes. Screening Case Report Form

Antihypertensive drugs SUMMARY Made by: Lama Shatat

REGISTRATION CRITERIA : SPECIALIST INITIATION OF TREATMENT AND FOR ANY SIGNIFICANT INCREASES IN DOSAGES OR ADDITION OF MEDICATION.

2 CARDIOVASCULAR SYSTEM

Section 3, Lecture 2

Alaska Medicaid 90 Day** Generic Prescription Medication List

Factors Involved in Poor Control of Risk Factors

STANDARD treatment algorithm mmHg

Information in these slides is used with permission from St. Mary s Cardiac Rehab

Ambetter 90-Day-Supply Maintenance Drug List

Sandwell and West Birmingham Hospitals NHS Trust

Heart Failure Clinician Guide JANUARY 2018

ISMJ International SportMed Journal

Therapeutic options for adult patients unable to take solid oral dosage forms (Adapted from UKMi Q&A for use in Northern Ireland) Sep 2015

Heart Failure Clinician Guide JANUARY 2016

Hypertension Management - Summary

What in the World is Functional Medicine?

Antihypertensive drugs: I. Thiazide and other diuretics:

Dose. Route. Units. Given. Special situations. Dose. Route. Units. Given. Special situations

8/20/2018. Objectives. What is hypertension? cont. What is hypertension? Epidemiology cont. Epidemiology

Professionalism & Service with Great Prices

Evaluation and Management of Acute Decompensated Heart Failure (HF) with Reduced Ejection Fraction Systolic Heart Failure (HFrEF)(EF<40%

Chapter 2 Cardiovascular System

DRUG CLASSIFICATION. Prevention of Cardiovascular Disease

Cardiovascular system

Combining Antihypertensives in People with Diabetes

Cardiovascular Clinical Practice Guideline Pilot Implementation

ACE inhibitors Captopril Tab 12.5 MG CAPTOHEXAL 12.5MG

Medicines for high blood pressure

Volume 6; Number 1 January 2012 NICE CLINICAL GUIDELINE 127: HYPERTENSION CLINICAL MANAGEMENT OF PRIMARY HYPERTENSION IN ADULTS (AUGUST 2011)

By Prof. Khaled El-Rabat

Hypertension is also an important risk factor in the development of chronic kidney disease and heart failure.

LESSON ASSIGNMENT. After completing this lesson you will be able to:

ADCO-CAPTOPRIL 25MG BIO-CAPTOPRIL 25MG MERCK-CAPTOPRIL 25MG SANDOZ CAPTOPRIL 25MG ZAPTO 25MG TAB

Codes for a Medicare claims-based model to predict LVEF class- User Guide

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 759 M %

PHARMACOLOGICAL PROBLEMS

While there is around a 3% increase shown in costs for Category M lines, I think this is due to the inclusion of more lines in Category M.

12.5mg, 25mg, 50mg. 25mg, 50mg. 250mg, 500mg, 250mg/5ml. 2.5mg, 5mg, 10mg. 5mg, 10mg, 20mg, 100mg. 25mg

Treatment of Essential Hypertension

$0 Preferred Generics List

ANTIHYPERTENSIVES. Assoc. Prof. Bilgen Başgut

Treatment of Essential Hypertension

Generic Drugs: What does equal really mean? Dr. Peter J. Lin Director Primary Care Initiatives Canadian Heart Research Centre

TREATMENT OF HEART FAILURE UNDER CURRENT GUIDELINES

Generic Preventive Care/ Safe Harbor Drug Program List

Cardiovascular Drugs

DT Description Price Category Price change

Drug Therapy of Heart Failure. Munir Gharaibeh, MD, PhD, MHPE Faculty of Medicine, The University of Jordan November, 2014

Heart Failure (HF) Treatment

7/7/ CHD/MI LVH and LV dysfunction Dysrrhythmias Stroke PVD Renal insufficiency and failure Retinopathy. Normal <120 Prehypertension

Heart Failure. Dr. Alia Shatanawi

Antihypertensive Drugs. Nafrialdi

Drug Schedule For RC 143(A)

Checklist for Treating Heart Failure. Alan M. Kaneshige MD, FACC, FASE Oklahoma Heart Institute

Towards a Greater Understanding of Cardiac Medications Foundational Cardiac Concepts That Must Be Understood:

Top 200 Section 4. Cardiovascular Drugs

Metabolic Consequences of Anti Hypertensives: Is It Clinically Important?

1/4/18. Heart Failure Guideline Review and Update. Disclosure. Pharmacist Objectives. Pharmacy Technician Objectives. What is Heart Failure?

Younger adults with a family history of premature artherosclerotic disease should have their cardiovascular risk factors measured.

Treatment of T Angina reatment of By Ali Alalawi

Antihypertensives. Antihypertensive Classes. RAAS Inhibitors. Renin-Angiotensin Cascade. Angiotensin Receptors. Approaches to Hypertension Treatment

sympatholytics sympatholytics sympatholytics

WRITER TRISTAN WALKER TABLE OF CONTENTS. The Basics of cardiac pharmacology 2007

Heart failure. Failure? blood supply insufficient for body needs. CHF = congestive heart failure. increased blood volume, interstitial fluid

Adapted d from Federation of Health Regulatory Colleges of Ontario Template Last Updated September 18, 2017

PassAssured's Pharmacy Technician Training Systems. Medication Review. Cardiovascular Drugs. Pharmacy Technician Training Systems Passassured, LLC

Medications. Your prescriptions can be filled by your home pharmacy or by the Michigan Medicine Taubman Center outpatient pharmacy.

DROGAS PARA HIPERTENSION ARTERIAL JONATHAN POVEDA FERNANDEZ HSJD / 2013 FACC/FSCAI/FESC

DT Description Price Category Price change Percentage BNF 1.2 Mebeverine 135mg tablets (100) 702 M %

Review Protocol Patient information

Effective January 2018

New classification of HT Systolic Diastolic Normal <120 <80 Prehypertension Stage1HT Stage 2 HT >160 or >100

Proposal Relating to the Funding of Certain Pharmaceuticals in DHB Hospitals

Transcription:

Chapter 2 ~ Cardiovascular System: General Section 1 of 6 Chapter 2 ~ Cardiovascular system 2.1 Positive inotropic drugs 2.1.1 Cardiac glycosides DIGOXIN 2.2 Diuretics Elixir 50micrograms in 1ml Injection 500micrograms in 2ml Tablet 62.5microgram; 125microgram; 250microgram 2.2.1 Thiazides and related diuretics BENDROFLUME- THIAZIDE INDAPAMIDE Tablet 2.5mg METOLAZONE Tablet 5mg 2.2.2 Loop diuretics BUMETANIDE FUROSEMIDE Tablet 2.5mg; 5mg Injection 2mg in 4ml Liquid 1mg in Tablet 1mg; 5mg Injection 20mg in 2ml Oral solution SF 50mg in Tablet 20mg; 40mg Tablet 500mg 2.2.3 Potassium-sparing diuretics and aldosterone antagonists AMILORIDE Tablet 5mg SPIRONOLACTONE Tablet 25mg; 100mg Oral suspension SF 50mg in 2.2.4 Potassium-sparing diuretics with other diuretics AMILORIDE with Tablet 5mg / 1mg bumetanide (BURINEX A ) CO-AMILOFRUSE Tablet 2.5mg / 20mg; (amiloride with 5mg / 40mg furosemide) CO-AMILOZIDE (amiloride with hydrochlorothiazide) CO-TRIAMTERZIDE (triamterene with hydrochlorothiazide) Tablet 2.5mg / 25mg; 5mg / 50mg Tablet 50mg / 25mg

Chapter 2 ~ Cardiovascular System: General Section 2 of 6 2.2.5 Osmotic diuretics MANNITOL 2.2.8 Diuretics with potassium BUMETANIDE with potassium (BURINEX K ) 2.3 Anti-arrhythmic drugs 2.3.2 Drugs for arrhythmias Intravenous infusion 10%; 20% Tablet 500micrograms / 7.7mmol Supraventricular and ventricular arrhythmias AMIODARONE Ventricular arrhythmias LIDOCAINE Sterile concentrate 150mg in 3ml Tablet 100mg; 200mg Injection 2%, 2ml; 2.4 Beta-adrenoceptor blocking drugs ATENOLOL BISOPROLOL FUMARATE CARVEDILOL LABETALOL METOPROLOL TARTRATE PROPRANOLOL SOTALOL Combination products CO-TENIDONE (atenolol with chlortalidone) Syrup SF 25mg in Tablet 25mg; 50mg; 100mg Tablet 1.25mg; 5mg; 10mg Tablet 3.125mg; 12.5mg; 25mg Injection 100mg in 20ml Tablet 50mg; 100mg; 200mg Injection 5mg in Tablet 50mg; 100mg Injection 1mg in 1ml Modified release capsule 80mg; 160mg Oral solution SF 5mg in ; 50mg in Tablet 10mg; 40mg Injection 40mg in 4ml Tablet 40mg; 80mg Tablet 50mg / 12.5mg; 100mg / 25mg 2.5 Drugs affecting the renin-angiotensin system and some other antihypertensive drugs 2.5.1 Vasodilator antihypertensive drugs HYDRALAZINE Injection 20mg Tablet 25mg; 50mg

Chapter 2 ~ Cardiovascular System: General Section 3 of 6 2.5.2 Centrally acting antihypertensive drugs METHYLDOPA Tablet 250mg 2.5.4 Alpha-adrenoceptor blocking drugs DOXAZOSIN PRAZOSIN 4mg; 8mg Tablet 1mg; 2mg; 4mg Tablet 500micrograms; 1mg Tablet 2mg; 5mg 2.5.5 Drugs affecting the renin-angiotensin system 2.5.5.1 Angiotensin-converting enzyme (ACE) inhibitors CAPTOPRIL ENALAPRIL LISINOPRIL PERINDOPRIL RAMIPRIL Tablet 12.5mg; 25mg; 50mg Tablet 2.5mg; 5mg; 10mg; 20mg Tablet 2.5mg; 5mg; 10mg; 20mg Tablet 2mg; 4mg Capsule 1.25mg; 2.5mg; 5mg; 10mg Tablet 1.25mg; 2.5mg; 5mg; 10mg 2.5.5.2 Angiotensin-II receptor antagonists CANDESARTAN Tablet 2mg; 4mg; 8mg IRBESARTAN Tablet 75mg; 150mg LOSARTAN Tablet 25mg; 50mg VALSARTAN Capsule 40mg; 80mg Tablet 40mg 2.6 Nitrates, calcium-channel blockers and potassium-channel activators 2.6.1 Nitrates GLYCERYL TRINITRATE ISOSORBIDE DINITRATE ISOSORBIDE MONONITRATE Injection 50mg in 10ml Patch 5mg / 24hours; 10mg / 24hours Spray 400micrograms / metered dose Sublingual tablet 500micrograms Tablet 10mg Tablet 10mg; 20mg 60mg 2.6.2 Calcium-channel blockers AMLODIPINE DILTIAZEM Tablet 5mg Tablet 10mg 60mg Adizem-XL modified

Chapter 2 ~ Cardiovascular System: General Section 4 of 6 release capsule 120mg; 180mg; 240mg; 300mg Adizem-SR modified release capsule 90mg; 120mg Tildiem LA modified release capsule 200mg; 300mg Tildiem Retard modified release tablet 90mg; 120mg FELODIPINE 2.5mg; 5mg Capsule 5mg; 10mg NIFEDIPINE NIMODIPINE VERAPAMIL Adalat LA modified release tablet 20mg; 30mg Adalat Retard modified release tablet 10mg; 20mg Injection 10mg in 50ml Tablet 30mg Injection 5mg in 2ml Oral solution SF 40mg in Tablet 40mg; 120mg Verapress MR modified release tablet 240mg 2.6.3 Potassium-channel activators NICORANDIL Tablet 10mg; 20 mg 2.6.4 Peripheral and cerebral vasodilators 2.6.4.1 Peripheral vasodilators and related drugs NAFTIDROFURYL Capsule 100 mg 2.7 Sympathomimetics 2.7.1 Inotropic sympathomimetics DOPAMINE Injection 200mg in 2.7.3 Cardiopulmonary resuscitation ADRENALINE/ EPINEPHRINE Injection 1 in 10,000 1ml amp; 10ml amp; 10ml prefilled syringe 2.8 Anticoagulants and protamine 2.8.1 Parenteral anticoagulants Heparins

Chapter 2 ~ Cardiovascular System: General Section 5 of 6 HEPARIN SODIUM Preservative free injection 5000 in 0.2ml; 1000units in 1ml; 5000units in 0.2ml; 5000units in ; 20000units in 20ml HEPARIN SODIUM IN 0.9% SODIUM CHLORIDE Intravenous infusion 1000units in 500ml Intravenous infusion 500units in 500ml Low Molecular Weight Heparins DALTEPARIN SODIUM Injection 2500units in 0.2ml 5000units in 0.2ml 7500units in 0.3ml 10,000units in 0.4ml 12,500units in 0. 15,000units in 0.6ml 18,000units in 0.72ml 10,000units in 4ml Heparin flushes HEPARIN SODIUM Hepsal Preservative free injection 50units in 2.8.2 Oral anticoagulants PHENINDIONE WARFARIN 2.8.3 Protamine sulphate PROTAMINE SULPHATE 2.9 Antiplatelet drugs ASPIRIN CLOPIDOGREL DIPYRIDAMOLE Tablet 10mg; 25mg; 50mg Tablet 0.5mg; 1mg; 3mg; 5mg Injection 50mg in Dispersible tablet 75mg Enteric coated tablet 75mg Tablet 75mg Tablet 25mg; 100mg Modified release capsule 200mg Suspension SF 50mg in 2.10 Myocardial infarction and fibrinolysis 2.10.2 Fibrinolytic drugs RETEPLASE Injection 10units 2.11 Antifibrinolytic drugs and haemostatics TRANEXAMIC ACID Injection 500mg in Tablet 500mg

Chapter 2 ~ Cardiovascular System: General Section 6 of 6 2.12 Lipid-regulating drugs Anion-exchange resins COLESTYRAMINE Powder 4g Powder, sugar-free SF 4g Fibrates BEZAFIBRATE FENOFIBRATE Statins ATORVASTATIN PRAVASTATIN SIMVASTATIN 400mg Tablet 200mg Capsule (micronised) 67mg; 200mg Tablet 10mg; 20mg; 40mg Tablet 10mg; 40mg Tablet 10mg; 20mg; 40mg